The interaction of programmed death 1 (PD-1) with the non-small-cell lung cancer (NSCLC) expressed ligands programmed death-ligand 1 (PD-L1) and PD-L2 could downregulate T cell activity and promote tumor immune escape [1–4]. Here, CD274 is linked to non-small cell lung carcinoma.